INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2016

A single dose of resveratrol acutely increased cerebral vasodilator responsiveness in older adults with type 2 diabetes, with 75 mg showing maximum benefit.

In a balanced crossover trial, 36 adults with type 2 diabetes consumed single doses of synthetic trans-resveratrol (0, 75, 150, and 300 mg) at weekly intervals. CVR to a hypercapnic stimulus was assessed by transcranial Doppler ultrasound before and 45 minutes after treatment. Resveratrol increased CVR in the middle cerebral arteries, with mean within-individual changes from placebo of 13.8 ± 3.5% for 75 mg (P = 0.001), 8.9 ± 3.5% for 150 mg (P = 0.016), and 13.7 ± 3.3% for 300 mg (P < 0.001). Only the 75 mg dose significantly increased CVR in the posterior cerebral arteries (13.2 ± 4.5%, P = 0.016).

Study type
Double-blind, placebo-controlled, balanced crossover trial
Who was studied
36 dementia-free, non-insulin dependent type 2 diabetes adults aged 49-78 years
What was measured
Cerebral vasodilator responsiveness (CVR) to hypercapnia in MCA and PCA

THE PAPER

Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus.

Wong RH, Nealon RS, Scholey A, Howe PR. Nutr Metab Cardiovasc Dis, 2016.

PubMed 27105868 ↗DOI 10.1016/j.numecd.2016.03.003 ↗

Diabetes & blood sugarBrain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.